A TREAT TO TARGET APPROACH DECREASES THE RATE OF CD-RELATED ADVERSE OUTCOMES VERSUS A CLINICAL APPROACH IN PATIENTS WITH MODERATE TO SEVERELY ACTIVE CROHN'S DISEASE: DATA FROM CALM

Jean-Frederic Colombel  ¹     Remo Panaccione  ²     Peter Bossuyt  ³     Filip Baert  ⁴     T. Vanásek  ⁵     Ahmet Danalıoğlu  ⁶     Gottfried Novacek  ⁷     Alessandro Armuzzi     Xavier Hebuterne     Simon Travis     Silvio Danese     Walter Reinisch     William Sandborn     Paul Rutgeerts     Daniel W. Hommes     Stefan Schreiber     Ezequiel Neimark     Bidan Huang     Qian Zhou     Wan J Le    
¹ Icahn School of Medicine at Mount Sinai,New York,United States of America
² University of Calgary,Calgary,Canada
³ Imelda General Hospital,Bonheiden,Belgium
⁴ AZ Delta,Roeselare,Belgium
⁵ Hepato-Gastroenterologie HK, s.r.o.,Hradec Králové,Czech Republic
⁶ Bezmialem Vakif University School Of Medicine,Gastroenterology,İstanbul,Turkey
⁷ Medi

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)